Redeye: Aspire Global - Regulatory Pressure

Redeye lowers Aspire Global´s base case due to lowered estimates to reflect increased regulatory challenges. However, we still see substantial upside in the stock after the negative share price reaction. Regulation led the important B2B segment to disappoint in Q4’19, but the company has taken measures to cope, and the PariPlay acquisition performed very well.

Read more and download the research update: http://bit.ly/2wFPFTR

Start following companies at Redeye to recieve the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/